​

  ​ ​ ​

2025

  ​ ​ ​

2024

Non-capital losses carried forward

​

$

34,810,450

​

$

24,850,000

Research and development expenditures

​

3,022,831

​

3,175,000

Investment tax credits

​

1,944,821

​

2,043,000

Tax value of technology rights and property and equipment in excess of accounting basis

​

160,999

​

193,000

Share issue costs

​

1,066,620

​

1,275,000

Non-deductible reserves

​

​

—

​

​

10,000

Restricted interest and financing expenses

​

—

​

337,000

Total deferred income tax assets

​

41,005,721

​

31,883,000

Valuation allowance

​

(41,005,721)

​

(31,883,000)

Net deferred income tax assets

​

$

—

​

$

—